25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Petlife Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Petlife Pharmaceuticals Inc together

I guess you are interested in Petlife Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Petlife Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Petlife Pharmaceuticals Inc

I send you an email if I find something interesting about Petlife Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Petlife Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Petlife Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.01
Expected worth in 1 year
$0.03
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$0.04
Return On Investment
37,680.1%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Petlife Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00

2.2. Growth of Petlife Pharmaceuticals Inc (5 min.)




Is Petlife Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.3m-$3.2m$1.8m134.2%

How much money is Petlife Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$23.2m-$3.6m-$19.5m-84.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Petlife Pharmaceuticals Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Petlife Pharmaceuticals Inc?

Welcome investor! Petlife Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Petlife Pharmaceuticals Inc.

First you should know what it really means to hold a share of Petlife Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Petlife Pharmaceuticals Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Petlife Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Petlife Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.01. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Petlife Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.12-118,203.9%-0.12-118,203.9%-0.02-18,739.5%-0.05-48,921.3%-0.05-48,921.3%
Usd Book Value Change Per Share0.019,420.0%0.019,420.0%-0.01-14,585.5%0.00-2,340.4%0.00-2,340.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.019,420.0%0.019,420.0%-0.01-14,585.5%0.00-2,340.4%0.00-2,340.4%
Usd Price Per Share0.13-0.13-0.15-0.10-0.10-
Price to Earnings Ratio-1.06--1.06--8.00--4.04--4.04-
Price-to-Total Gains Ratio13.27-13.27--10.28--4.39--4.39-
Price to Book Ratio-17.80--17.80--9.12--14.36--14.36-
Price-to-Total Gains Ratio13.27-13.27--10.28--4.39--4.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (10000000 shares)94,200.31-23,404.25
Gains per Year (10000000 shares)376,801.25-93,617.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103768013767910-93617-93627
207536037535920-187234-187244
30113040411303930-280851-280861
40150720515071940-374468-374478
50188400618839950-468085-468095
60226080822607960-561702-561712
70263760926375970-655319-655329
80301441030143980-748936-748946
90339121133911990-842553-842563
100376801337680000-936170-936180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.02.00.033.3%1.02.00.033.3%1.02.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.02.00.033.3%1.02.00.033.3%1.02.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Petlife Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0090.0090%-0.015+255%-0.002+125%-0.002+125%
Book Value Per Share---0.007-0.0070%-0.016+134%-0.008+20%-0.008+20%
Current Ratio--0.0380.0380%0.000+10473%0.017+123%0.017+123%
Debt To Asset Ratio--26.11526.1150%2761.119-99%951.950-97%951.950-97%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps---0.118-0.1180%-0.019-84%-0.049-59%-0.049-59%
Free Cash Flow Per Share---0.002-0.0020%-0.001-52%-0.001-48%-0.001-48%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000+4429%0.000+236%0.000+236%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap19675.200-124900%24594000.00024594000.0000%29512800.000-17%20003120.000+23%20003120.000+23%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-0.014+100%-17.803-17.8030%-9.123-49%-14.364-19%-14.364-19%
Pe Ratio-0.001+100%-1.057-1.0570%-8.004+657%-4.039+282%-4.039+282%
Price Per Share0.000-124900%0.1250.1250%0.150-17%0.102+23%0.102+23%
Price To Free Cash Flow Ratio-0.062+100%-77.117-77.1170%-194.369+152%-177.423+130%-177.423+130%
Price To Total Gains Ratio0.011-124900%13.27013.2700%-10.284+178%-4.393+133%-4.393+133%
Quick Ratio----0%-0%0.004-100%0.004-100%
Return On Assets---422.821-422.8210%-3145.939+644%-1308.858+210%-1308.858+210%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share--0.0090.0090%-0.015+255%-0.002+125%-0.002+125%
Usd Book Value---1381450.000-1381450.0000%-3234860.000+134%-1660479.000+20%-1660479.000+20%
Usd Book Value Change Per Share--0.0090.0090%-0.015+255%-0.002+125%-0.002+125%
Usd Book Value Per Share---0.007-0.0070%-0.016+134%-0.008+20%-0.008+20%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.118-0.1180%-0.019-84%-0.049-59%-0.049-59%
Usd Free Cash Flow---318918.000-318918.0000%-151839.000-52%-164463.667-48%-164463.667-48%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.001-52%-0.001-48%-0.001-48%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000+4429%0.000+236%0.000+236%
Usd Market Cap19675.200-124900%24594000.00024594000.0000%29512800.000-17%20003120.000+23%20003120.000+23%
Usd Price Per Share0.000-124900%0.1250.1250%0.150-17%0.102+23%0.102+23%
Usd Profit---23256850.000-23256850.0000%-3687040.000-84%-9625363.667-59%-9625363.667-59%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.0090.0090%-0.015+255%-0.002+125%-0.002+125%
 EOD+1 -7MRQTTM+0 -0YOY+15 -115Y+17 -1010Y+17 -10

3.3 Fundamental Score

Let's check the fundamental score of Petlife Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.001
Price to Book Ratio (EOD)Between0-1-0.014
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.038
Debt to Asset Ratio (MRQ)Less than126.115
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-422.821
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Petlife Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Petlife Pharmaceuticals Inc

  • 1
  • 8033 Sunset Boulevard, Los Angeles, CA, United States, 90046
    Google Maps Bing Maps

Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injectable version for direct administration to a tumor. In addition, the company develops edible dog and cat treats. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California.

Fundamental data was last updated by Penke on 2024-11-27 17:08:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Petlife Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Petlife Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Petlife Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.1.2. Return on Assets

Shows how efficient Petlife Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Petlife Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -42,282.1% Return on Assets means that Petlife Pharmaceuticals Inc generated $-422.82 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Petlife Pharmaceuticals Inc:

  • The MRQ is -42,282.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -42,282.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42,282.1%TTM-42,282.1%0.0%
TTM-42,282.1%YOY-314,593.9%+272,311.7%
TTM-42,282.1%5Y-130,885.8%+88,603.7%
5Y-130,885.8%10Y-130,885.8%0.0%
4.3.1.3. Return on Equity

Shows how efficient Petlife Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Petlife Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Petlife Pharmaceuticals Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Petlife Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Petlife Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Petlife Pharmaceuticals Inc is operating .

  • Measures how much profit Petlife Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Petlife Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Petlife Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Petlife Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Petlife Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Petlife Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Petlife Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.04 means the company has $0.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Petlife Pharmaceuticals Inc:

  • The MRQ is 0.038. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.038. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.038TTM0.0380.000
TTM0.038YOY0.000+0.038
TTM0.0385Y0.017+0.021
5Y0.01710Y0.0170.000
4.4.3.2. Quick Ratio

Measures if Petlife Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Petlife Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Petlife Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.004-0.004
5Y0.00410Y0.0040.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Petlife Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Petlife Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Petlife Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 26.12 means that Petlife Pharmaceuticals Inc assets are financed with 2,611.5% credit (debt) and the remaining percentage (100% - 2,611.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Petlife Pharmaceuticals Inc:

  • The MRQ is 26.115. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 26.115. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ26.115TTM26.1150.000
TTM26.115YOY2,761.119-2,735.004
TTM26.1155Y951.950-925.835
5Y951.95010Y951.9500.000
4.5.4.2. Debt to Equity Ratio

Measures if Petlife Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Petlife Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Petlife Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Petlife Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Petlife Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.06 means the investor is paying $-1.06 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Petlife Pharmaceuticals Inc:

  • The EOD is -0.001. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.057. Based on the earnings, the company is expensive. -2
  • The TTM is -1.057. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-1.057+1.057
MRQ-1.057TTM-1.0570.000
TTM-1.057YOY-8.004+6.947
TTM-1.0575Y-4.039+2.981
5Y-4.03910Y-4.0390.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Petlife Pharmaceuticals Inc:

  • The EOD is -0.062. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -77.117. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -77.117. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.062MRQ-77.117+77.055
MRQ-77.117TTM-77.1170.000
TTM-77.117YOY-194.369+117.252
TTM-77.1175Y-177.423+100.306
5Y-177.42310Y-177.4230.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Petlife Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -17.80 means the investor is paying $-17.80 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Petlife Pharmaceuticals Inc:

  • The EOD is -0.014. Based on the equity, the company is expensive. -2
  • The MRQ is -17.803. Based on the equity, the company is expensive. -2
  • The TTM is -17.803. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.014MRQ-17.803+17.789
MRQ-17.803TTM-17.8030.000
TTM-17.803YOY-9.123-8.680
TTM-17.8035Y-14.364-3.439
5Y-14.36410Y-14.3640.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2017-08-31. Currency in USD. All numbers in thousands.

Summary
Total Assets55
Total Liabilities1,436
Total Stockholder Equity-1,381
 As reported
Total Liabilities 1,436
Total Stockholder Equity+ -1,381
Total Assets = 55

Assets

Total Assets55
Total Current Assets55
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 54
Total Current Assets  (as reported)55
Total Current Assets  (calculated)54
+/- 1
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,436
Long-term Liabilities0
Total Stockholder Equity-1,381
Total Current Liabilities
Short-term Debt 717
Short Long Term Debt 717
Accounts payable 377
Other Current Liabilities 112
Total Current Liabilities  (as reported)1,436
Total Current Liabilities  (calculated)1,924
+/- 488
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock74
Total Stockholder Equity (as reported)-1,381
Total Stockholder Equity (calculated)74
+/- 1,455
Other
Common Stock Shares Outstanding 73,842
Net Debt 663
Net Invested Capital -668
Net Tangible Assets -1,385
Net Working Capital -1,381



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2017-08-312016-08-312015-08-312014-08-31
> Total Assets 
17
5
1
55
551517
   > Total Current Assets 
17
5
1
55
551517
       Cash And Cash Equivalents 
7
0
1
54
54107
       Net Receivables 
11
5
0
0
00511
   > Long-term Assets 0000
       Property Plant Equipment 
0
1
0
0
0010
       Intangible Assets 
0
1
0
0
0010
> Total Liabilities 
0
371
3,236
1,436
1,4363,2363710
   > Total Current Liabilities 
0
371
3,236
1,436
1,4363,2363710
       Short-term Debt 
0
10
153
717
717153100
       Short Long Term Debt 
0
10
153
717
717153100
       Accounts payable 
0
361
758
377
3777583610
       Other Current Liabilities 
0
0
2,325
112
1122,32500
   > Long-term Liabilities 0000
> Total Stockholder Equity
17
-365
-3,235
-1,381
-1,381-3,235-36517
   Common Stock
55
12
8
74
7481255
   Retained Earnings Total Equity0000
   Accumulated Other Comprehensive Income 0000
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 0000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2017-08-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-18
Gross Profit-18-18
 
Operating Income (+$)
Gross Profit-18
Operating Expense-22,385
Operating Income-22,385-22,403
 
Operating Expense (+$)
Research Development0
Selling General Administrative22,385
Selling And Marketing Expenses0
Operating Expense22,38522,385
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-384
Net Interest Income-384
 
Pretax Income (+$)
Operating Income-22,385
Net Interest Income-384
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-23,257-21,898
EBIT - interestExpense = -22,403
-23,257
-23,257
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-22,403-23,257
Earnings Before Interest and Taxes (EBITDA)-22,873
 
After tax Income (+$)
Income Before Tax-23,257
Tax Provision-0
Net Income From Continuing Ops-23,257-23,257
Net Income-23,257
Net Income Applicable To Common Shares-23,257
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring270
Other Operating Expenses0
Total Other Income/Expenses Net-488384
 

Technical Analysis of Petlife Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Petlife Pharmaceuticals Inc. The general trend of Petlife Pharmaceuticals Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Petlife Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Petlife Pharmaceuticals Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Petlife Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Petlife Pharmaceuticals Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Petlife Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartPetlife Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Petlife Pharmaceuticals Inc. The current adx is .

Petlife Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartPetlife Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Stochastic Oscillator ChartPetlife Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartPetlife Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartPetlife Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Williams %R ChartPetlife Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Average True Range (ATR) ChartPetlife Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartPetlife Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartPetlife Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Petlife Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Petlife Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Petlife Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Petlife Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Petlife Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Petlife Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Petlife Pharmaceuticals Inc

I send you an email if I find something interesting about Petlife Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Petlife Pharmaceuticals Inc.

Receive notifications about Petlife Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.